European Pharmaceutical Review

FEBRUARY 17, 2025

While this investment led to a seven percent rise in annual apprenticeship starts within the life sciences sector between 2018/19 and 2022/23, industry leaders have consistently argued that the narrow focus on apprenticeships left gaps in training provision. billion in 2017/18 to 2.5 billion in 2023/24.

Training 59

Training Pharmaceutical Government Manufacturing 59

Integrity Solutions

MARCH 4, 2019

Market leaders recognize that exceptional customer experience can become a powerful guard against industry volatility and a huge competitive advantage. Writing for Forbes about Sitel Group’s 2018 Customer Experience (CX) Index report, Dan Gingiss emphasizes, “The human-to-human connection is key to a great customer experience.

Relationship management 152

Relationship management Competition Marketing Sales 152

Medical Device Success

OCTOBER 18, 2020

Reading time: 2 – 3 minutes In January 2018 when Dominik Beck took the helm of Rudolf Riester, GmbH, he began executing a plan to put Riester in a more competitive position against its larger rivals. Then in early 2020 Covid spread across the world. But to take advantage of an opportunity, you have to execute.

Leads 100

Leads Doctors Medical Competition 100

Evolve Your Success

MARCH 12, 2025

That’s a very it’s an extremely competitive space where there are other spaces and they may have no competitor. You’re the only device that solves that problem, so your need to sell isn’t as strong as when you’re working in maybe a more competitive space where there’s a lot of me too products.

Medical sales 130

Medical sales Sales Medical Patients 130

Integrity Solutions

JANUARY 29, 2019

In fact, fewer than half (46%) of the firms we surveyed as part of our 2018 Sales Coaching Research study believe they are effective at coaching salespeople. Of course, that means the few organizations that are doing it right can claim a huge competitive advantage. That’s a 15% gap. And it’s a huge issue for many businesses today.

Sales 192

Sales Sales Management Management Product Knowledge 192

European Pharmaceutical Review

NOVEMBER 28, 2024

When the General Data Protection Regulation (GDPR) 1 came into effect in 2018, this appeared to accelerate the migration out of Europe for pharmaceutical clinical trials. This was not so much due to non-compliance but stemmed from regulatory ambiguity.

Medical 105

Medical Government Safety Management 105

Pharmaceutical Technology

JANUARY 23, 2023

in revenue across seven major markets (7MM: US, France, Germany, Italy, Spain, UK and Japan) in 2018, and also was the first approved biologic therapy for LN in the US, having gained approval in 2020. However, the 2021 approval of AstraZeneca’s Saphnelo in the US will mean increasing competition for Benlysta in the coming years.

Marketing 111

Marketing Safety Patients Pharmaceutical 111

European Pharmaceutical Review

JULY 18, 2022

The deal is expected to close by the end of 2022, subject to approval by the relevant competition authorities. In 2018, Grünenthal acquired the European rights to Nexium as well as the global rights to Vimovo (ex-US and Japan) from AstraZeneca.

Medicine 98

Medicine Physicians Competition Patients 98

European Pharmaceutical Review

MAY 3, 2023

Influencing factors identified in the report include higher competition, competitive pricing and inflation rate, technological advancements and evolving regulatory guidelines. These factors have led to industry 4.0 technologies.

Marketing 105

Marketing Manufacturing Biopharma Competition 105

pharmaphorum

SEPTEMBER 5, 2022

The UK Competition and Markets Authority (CMA) is seeking to disqualify Peter Butterfield, currently chief executive of Alliance Pharma, from serving as a company director. ” The action will only be heard if the Competition Appeal Tribunal (CAT) upholds the CMA’s findings against Alliance, it added. .”

Pharma 59

Pharma Competition Management Marketing 59

European Pharmaceutical Review

AUGUST 23, 2022

1 The regulation is the culmination of a long debate between European Union (EU) Member States and health sector stakeholders, triggered by joint actions such as European Network for Health Technology Assessment (EUnetHTA) and formalised through the European Commission (EC)’s proposal in January 2018. European Commission; 2018.

Consulting 98

Consulting Medical Healthcare Healthcare 98

Clarivate

NOVEMBER 16, 2021

We name 332 researchers on our list at research institutes in Australia this year – an increase in share to 5% (from 4% in 2018). On the other side of the world, in a country of 25 million, research institutes in Australia continue to punch above their weight. Australia edges into fourth place ahead of Germany.

Government 136

Government Competition Recruitment Leads 136

pharmaphorum

NOVEMBER 17, 2022

The 2019 VPAS agreement was published on 5 December 2018 and an annexe showed that growth rate of branded medicines spend was expected to go up over time. Source: DHSC (2018) and DHSC (2022). The BGMA has already highlighted how they were not involved in the 2018 negotiations. It follows that the payment percentage would too.

Government 98

Government Sales Medicine Consulting 98

European Pharmaceutical Review

OCTOBER 27, 2023

If achieved, this would boost the UK’s competitiveness as a leading international site for trials. Benefits of The Future Clinical Trials Bill Chiefly, the Bill’s goal is to increase patient participation and overall, ensure clinical trials have the highest levels of safety while enabling greater regulatory pragmatism, the author explained.

Ethics 105

Ethics Medicine Education Competition 105

Clarivate

DECEMBER 7, 2021

The previously clear lines between sectors are blurring and the competitive set is widening. 4] By delving deeper into the trademark filing activity of Louis Vuitton, we observed a spike in filing in the computer games and software category for 2018 and 2019, which preceded the launch of the game, Louis.

Professional Services 95

Professional Services Management Competition Sales 95

Pharmaceutical Technology

MARCH 24, 2023

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. For example, the cost of Humira biosimilars in Denmark decreased by 82% from September 2018 to December 2018. Biosimilars launched in the US have seen slow uptake due to several reasons.

Competition 59

Competition Marketing FDA Physicians 59

Pharmaceutical Technology

MAY 19, 2023

The first approved biosimilar in the US and EU was Celltrion/Teva Pharmaceutical’s Truxima/Blitzima in 2018 and 2017, respectively. However, in the second year of biosimilar competition, Rituxan sales started to significantly erode. In Japan, the first biosimilar was Pfizer’s Rituximab in 2019.

Sales 59

Sales Competition Marketing Patients 59

Clarivate

MARCH 8, 2022

In 2018, with continued support from the university, he was selected as a scholar of the Columbus Program by the Ministry of Science and Technology (MOST). In today’s competitive academic environment, it is possible to overemphasize the importance of immediate results and performance.

Engineering 98

Engineering Government Competition Networking 98

pharmaphorum

JULY 27, 2022

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”.

Government 98

Government Recruitment Medicine Patients 98

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009.

Pharma 119

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 119

pharmaphorum

AUGUST 31, 2022

BIVV001 is a Factor VIII replacement therapy that is being developed as a successor to Eloctate (efmoroctocog alfa), Sanofi and Sobi’s current Factor VIII drug that is dosed every four days and has seen its sales decline in an increasingly competitive market. The drug was one of the primary drivers for Sanofi’s $11.6

Competition 52

Competition Marketing Sales Patients 52

pharmaphorum

JANUARY 4, 2023

In an update on the litigation posted this morning, Astellas confirmed that the Court of Appeals for the Federal Circuit (CAFC) had upheld a lower court ruling that Hospira’s generic does not infringe any of the patents that are protecting Lexiscan (regadenoson injection) from competition.

Pharmacology 59

Pharmacology Marketing Pharma Competition 59

pharmaphorum

JANUARY 25, 2023

To ensure an optimised engagement model critical to long-term success in today’s highly competitive commercial market, life sciences companies need to effectively leverage AI-powered technology. Organisations need to develop an integrated end-to-end commercial strategy to fuel data-driven insights and guide decision-making.

Marketing 98

Marketing Sales Retail Management 98

CloserIQ

JANUARY 11, 2019

“Even though natural-born salespeople are very competitive by their very nature, it’s good to have competition for motivation. “In the US, more VC-backed companies went public during 2018 than had in a number of years. ” NYC Seed Funding Holds Steady as 2018 Draws to a Close (AlleyWatch).

Sales 53

Sales Sales process Competition Management 53

Pharma Marketing Network

OCTOBER 26, 2020

According to Bio-IT World, “between 2018 and 2019, 510 healthcare data breaches of 500 or more records were reported, representing a 196% increase in such attacks.”. 3 Ways Pharma Can Guarantee Competitive Cybersecurity. Data protection complexity grows when pharma companies transfer personal data internationally.

Pharmaceutical 96

Pharmaceutical Pharma Specialization Healthcare 96

Salesforce

MARCH 3, 2022

Tuning the equipment, even the smallest bit, is crucial when fractions of second matter in competition. He recalled a story from the 2018 Paralympic Games where an American teammate edged him out for the gold. “I And now they’re using Salesforce’s Customer 360 to dial up the wow. Learn more. Paralympians will perform using his designs.

Specialization 98

Specialization Competition Medical 98

The Brooks Group

DECEMBER 26, 2018

Check out the 4 most popular episodes in 2018 and set your team up for success in the New Year! The Simple Formula Your Salespeople Can Use to Master Storytelling and Outsell the Competition. We developed this series to efficiently deliver practical sales leadership tips and strategies that you can apply with your team immediately.

Sales 40

Sales Training Competition Leads 40

Pharmaceutical Technology

JANUARY 22, 2023

In 2022, the FDA approved only 37 new medicines, an underwhelming number compared to 98 in 2018. However, while only around 34% of the approvals in 2018 were for orphan drugs, 54% new approvals in 2022 were for drugs to treat rare diseases. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

FDA 126

FDA Safety Pharmaceutical Patients 126

Clarify Health

NOVEMBER 29, 2022

With “healthcare consumerism” on the rise, healthcare providers will need to change the way they market, deliver, and charge for services in order to remain competitive. Published: May 10, 2018. Taking a patient-centric approach to drive patient loyalty. Sources: 1 Artiga, S., 2019, July 9). 2 World Health Organization.

Healthcare 52

Healthcare Healthcare Healthcare Provider Patients 52

Pharmaceutical Technology

DECEMBER 4, 2022

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Humira biosimilars became available in the EU in October 2018. There are seven FDA-approved Humira biosimilars, of which Amgen’s Amjevita will be launched in January.

Marketing 104

Marketing Physicians Competition Patients 104

European Pharmaceutical Review

FEBRUARY 22, 2023

1,7 It may depend on the competition between 6 Li and 7 Li, present at much higher concentration, to be ionised. Gas-phase complexation of a/b-cyclodextrin with amino acids studied by ion mobility-mass spectrometry and molecular dynamics simulations, Talanta 2018, 186, 1-7. percent and 7.5= Chen Y, Zou Z, Dai X, et al. Schalley CA.

Food 98

Food Electronics Pharmaceutical Medical 98

pharmaphorum

JULY 11, 2022

Efanesoctocog alfa is being developed as a successor to Eloctate (efmoroctocog alfa), Sanofi and Sobi’s current factor VIII drug that is dosed every four days but has seen its sales decline in an increasingly competitive market. Sanofi acquired the drug when it bought Bioverativ in 2018 for $11.6

Engineering 52

Engineering Side effects Competition Sales 52

Healthcare Success

MAY 19, 2022

By 2018, that percentage had fallen to 54%. This step is particularly crucial in an era where new competition enters the market every day. One of the best ways to do this is through competitive analysis. Market share is a key indicator of how competitive you are in a particular space (e.g., Reconsider your brand strategy.

Marketing 52

Marketing Physicians Doctors Competition 52

Evolve Your Success

JULY 25, 2023

Talk to us a little bit about the competitive nature of your role. What does the competition look like in your space? That is good because, with a great product with a great company that produces good data, competition is easy to fight off. It is competitive, but it is a friendly competition. This was in 2018.

Sales 130

Sales Medical sales Medical Competition 130

Pharmaceutical Technology

MARCH 6, 2023

Tuoyi received marketing authorisation in China for six oncology indications, including NPC, in December 2018. Keytruda, however, has very limited OS data in patients with NPC versus chemotherapy, so the trial design of Tuoyi would give it a great competitive advantage in NPC, should it receive FDA approval.

FDA 52

FDA Patients Competition Leads 52

Contrarian Sales Techniques

NOVEMBER 4, 2024

2011-2018: The company grew quickly, carving out a stronghold in the e-commerce landscape. 2018: Fashion Valet’s growth caught the attention of government-linked investors, with Khazanah and PNB collectively investing RM47 million. The recent sale of stakes at a loss underscores these struggles.

Government 40

Government Competition Marketing Sales 40

pharmaphorum

JANUARY 4, 2023

Despite the introduction of the GDPR 3 in 2018, studies have demonstrated that the legislation has, unfortunately, been unevenly implemented and interpreted throughout by Member States. It has been proposed that the amount of these fees charged by the data holder must be transparent, proportionate, and “must not restrict competition” 10.

Pharmaceutical 98

Pharmaceutical Electronics Healthcare Healthcare 98